#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Fixed-dose combination therapy for hypertension


Authors: J. Špinar 1;  J. Vítovec 2;  L. Špinarová 2
Authors‘ workplace: Interní kardiologická klinika LF MU a FN Brno 1;  I. interní kardioangiologická klinika LF MU a FN u sv. Anny v Brně 2
Published in: Kardiol Rev Int Med 2016, 18(2): 85-93

Overview

We present an overview of current opinions on the position of fixed-dose combinations in the treatment of hypertension in line with the ESH/ ESC and the Czech Society for Hypertension guidelines of 2013. The most frequently recommended double combinations are a renin angiotensin system inhibitor (ACE-I or sartan) plus a calcium antagonist, a renin angiotensin system inhibitor plus a diuretic, or a calcium antagonist plus a diuretic. A fixed-dose combination of an ACE inhibitor (perindopril), a calcium channel blocker (amlodipine) and a diuretic (indapamide) was introduced in the Czech market in 2014. The main advantage of fixed combinations is improved patient compliance, leading to a better control of hypertension. A triple combination is required for good control of hypertension in about one third of patients.

Keywords:
hypertension –  fixed-dose combination –  triple combination


Sources

1. Filipovský J, Widimský J jr, Ceral J et al. Dia­gnostické a léčebné postupy u arteriální hypertenze, verze 2012: Doporučení České společnosti pro hypertenzi. Vnitř Lék 2012; 58: 785– 801.

2. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ ESC Guidelines for the management of arterial hypertension. J Hypertens 2013; 31: 1281– 1357. doi: 10.1097/ 01.hjh.0000431740.32696.cc.

3. Wolf-Maier K, Cooper RS, Banegas JR et al. Hypertension prevalence and blood pres­sure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363– 2369.

4. Cífková R, Škodová Z, Bruthans J et al. Longitudinal trends in cardiovascular mortality and blood pres­sure levels, prevalence, awarenes­s, treatment, and control of hypertension in the Czech population from 1985 to 2007/ 2008. J Hypertens 2010; 28: 2196– 2203. doi: 10.1097/ HJH.0b013e32833d4451.

5. Bramlage P, Bohm M, Volpe M et al. A global perspective on blood pres­sure treatment and control in a refer­red cohort of hypertensive patiens. J Clin Hypertens 2010; 12: 666– 677. doi: 10.1111/ j.1751-7176.2010.00322.x.

6. Wald DS, Law M, Mor­ris JK et al. Combination therapy versus monotherapy in reduc­ing blood pres­sure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009; 122: 290– 300. doi: 10.1016/ j.amjmed.2008.09.038.

7. Dahlöf B, Sever PS, Poulter NR et al. The ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine add­ing perindopril as required versus atenolol add­ing bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pres­sure Lower­ing Arm (ASCOT-BPLA): a multicentre randomised control­led trial. Lancet 2005; 366: 895– 906.

8. Kettani FZ, Dragomir A, Côté R et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009; 40: 213– 220. doi: 10.1161/ STROKEAHA. 108.522193.

9. Peters R, Beckett N, For­rete F et al. Incident dementia and blood pres­sure lower­ing in the HYpertensiuon in Very Elderly Trial cognitive function as­sement. Lance Neurol 2008; 7: 683– 689. doi: 10.1016/ S1474-4422(08)70143-1.

10. Mancia G, Laurent S, Agabiti-Rosei E et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121– 2258. doi: 10.1097/ HJH.0b013e328333146d.

11. Bangalore S, Kamalakkan­nan G, Parkar S et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120: 713– 719.

12. Vítovec J, Špinar J. Kombinační léčba hypertenze s přihlédnutím k fixním kombinacím. Kardiol Rev Int Med 2014; 16: 71– 74.

13. Špinar J, Vítovec J. Kombinační léčba hypertenze. Causa Subita 2012; 15: 10– 13.

14. Souček M, Řiháček I. Léčba hypertenze v rámci metabolického syndromu. Kardiol Rev Int Med 2010; 12: 73– 76.

15. Nis­sen SE, Tuzcu EM, Libby P et al. Ef­fect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pres­sure: the CAMELOT study: a randomized control­led trial. JAMA 2004; 292: 2217– 2225.

16. Tatti P, Pahor M, Byington RP et al. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998; 21: 597– 603.

17. Tobe S, Kawecka-Jaszcz K, Zan­nad F et al. Amlodipine added to quinapril vs quinapril alone for the treatment of hypertension in diabetes: the Amlodipine in Diabetes (ANDI) trial. J Clin Hypertens (Green­wich) 2007; 9: 120– 127.

18. Dahlöf B, Sever PS, Poulter NR et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine add­ing perindopril as required versus atenolol add­ing bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pres­sure Lower­ing Arm (ASCOT-BPLA): a multicentre randomised control­led trial. Lancet 2005; 366: 895– 906.

19. Poulter NR, Wedel H, Dahlöf B et al. Role of blood pres­sure and other variables in the dif­ferential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pres­sure Lower­ing Arm (ASCOT-BPLA). Lancet 2005; 366: 907– 913.

20. Jamerson K, Weber MA, Bakris GL et al. Benazepril plus amlodipine or hydrochlorothazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417– 2428. doi: 10.1056/ NEJMoa0806182.

21. Bakris GL, Sarafidis PA, Weir MR et al. Renal outcomes with dif­ferent fixed-dose combination ther­apies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised control­led trial. Lancet 2010; 375: 1173– 1181. doi: 10.1016/ S0140-6736(09)62100-0.

22. Vítovec J, Špinar J. Perindopril/ indapamid –  fixní kombinace. Remedia 2007; 17: 247– 257.

23. van Vark LC, Bertrand M, Akkerhuis KM et al. Angiotensin-convert­ing enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin- angiotensin- aldosterone system inhibitors involv­ing 158 998 patients. Eur Heart J 2012; 33: 2088– 2097. doi: 10.1093/ eurheartj/ ehs075.

24. Patel A, MacMahon S, Chalmers J et al. ADVANCE Col­laborative Group. Ef­fects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mel­litus (the ADVANCE trial): a randomised control­led trial. Lancet 2007; 370: 829– 840.

25. Gradman AH, Acevedo C. Evolv­ing strategies for the use of combination therapy in hypertension. Curr Hypertens Rep 2002; 4: 343– 349.

26. Špinar J, Vítovec J. Kombinační léčba hypertenze. Causa Subita 2012; 15: 10– 13.

27. Hess G, Hill J, Lau H et al. Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy. P T 2008; 33: 652– 666.

28. James PA, Oparil S, Carter BL et al. 2014 Evidence-based guideline for the management of high blood pres­sure in adultsreport from the panel members appointed to the Eighth Joint National Com­mittee (JNC 8). JAMA 2014; 311: 507– 520. doi: 10.1001/ jama.2013.284427.

29. Deeks ED. Amlodipine/ valsartan/ hydrochlorothiazide: fixed-dose combination in hypertension. Am J Cardiovasc Drugs 2009; 9: 411– 418. doi: 10.2165/ 11204350-000000000-00000.

30. Widimský J jr. První fixní trojkombinace perindopril arginin-indapamid-amlodipin: nový přístup v kombinační léčbě hypertenze. Vnitř Lék 2014; 60: 801– 807.

31. Widimský J jr. Trojkombinace v léčbě hypertenze. Kardiol Rev Int Med 2014; 16: 449– 453.

32. Widimský J jr. Na český trh přichází vůbec první fixní antihypertenzní trojkombinace. Practicus 2014; 8: 29.

Labels
Paediatric cardiology Internal medicine Cardiac surgery Cardiology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#